Category: Cardiovascular medicine, US

Semaglutide’s CVD indication could cost US Medicare $145bn extra a year

August 28, 2024 British Medical Journal Off BMJ, British Medical Journal, Cardiovascular medicine, US, Science and Health, Science and Research, Uncategorized